{rfName}
Ce

Indexed in

License and use

Icono OpenAccess

Citations

13

Altmetrics

Analysis of institutional authors

Hurtado CAuthorMontejo CAuthorAlonso MAuthor

Share

Publications
>
Article

Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome

Publicated to:Pharmaceutics. 14 (7): 1392- - 2022-07-01 14(7), DOI: https://doi.org/10.3390/ pharmaceutics14071392

Authors: Villa-Hermosilla, Monica-Carolina; Negro, Sofia; Barcia, Emilia; Hurtado, Carolina; Montejo, Consuelo; Alonso, Mario; Fernandez-Carballido, Ana

Affiliations

Abstract

Keywords

alveolar macrophagesautofluorescencecelecoxibcoronavirus disease 2019covid-19deliveryil-1-betainhalationmacrophagesmicroparticlesparticlesphagocytosisplgaplga microspherestnf-alphaCelecoxibCovid-19InhalationMacrophagesMicroparticlesPlgaSolid lipid nanoparticles

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Pharmaceutics due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 50/278, thus managing to position itself as a Q1 (Primer Cuartil), in the category Pharmacology & Pharmacy.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-05-31:

  • WoS: 8
  • Europe PMC: 5

Impact and social visibility

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.